AIMarketStock 0 FeesIPO Earn
196170 logo

196170 (196170)

Company Profile

Contact Information

Market News

  • Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 20262026-06-10T09:00
  • Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics2026-03-25T12:00
  • Alteogen stock initiated with Sell rating at UBS on overvaluation concerns2025-08-13T12:16:26

Financial Highlights

loading